Published in Antioxid Redox Signal on May 25, 2011
LOX-1, mtDNA damage, and NLRP3 inflammasome activation in macrophages: implications in atherogenesis. Cardiovasc Res (2014) 1.54
NADPH oxidases in heart failure: poachers or gamekeepers? Antioxid Redox Signal (2012) 1.27
Angiotensin II, NADPH oxidase, and redox signaling in the vasculature. Antioxid Redox Signal (2012) 1.27
LOX-1 in atherosclerosis: biological functions and pharmacological modifiers. Cell Mol Life Sci (2012) 1.04
Abrogation of lectin-like oxidized LDL receptor-1 attenuates acute myocardial ischemia-induced renal dysfunction by modulating systemic and local inflammation. Kidney Int (2012) 0.86
Oxidized low-density lipoprotein is a common risk factor for cardiovascular diseases and gastroenterological cancers via epigenomical regulation of microRNA-210. Oncotarget (2015) 0.83
Unveiling LOX-1 receptor interplay with nanotopography: mechanotransduction and atherosclerosis onset. Sci Rep (2013) 0.83
Oxidized low density lipoprotein (LDL) affects hyaluronan synthesis in human aortic smooth muscle cells. J Biol Chem (2013) 0.82
Ox-LDL Upregulates IL-6 Expression by Enhancing NF-κB in an IGF2-Dependent Manner in THP-1 Macrophages. Inflammation (2015) 0.79
Structure-based Design Targeted at LOX-1, a Receptor for Oxidized Low-Density Lipoprotein. Sci Rep (2015) 0.78
The lectin-like oxidized LDL receptor-1: a new potential molecular target in colorectal cancer. Oncotarget (2016) 0.77
Local oxidative and nitrosative stress increases in the microcirculation during leukocytes-endothelial cell interactions. PLoS One (2012) 0.76
Essential Oils from Fructus A. zerumbet Protect Human Aortic Endothelial Cells from Apoptosis Induced by Ox-LDL In Vitro. Evid Based Complement Alternat Med (2014) 0.75
Adiponectin ameliorates angiotensin II-induced vascular endothelial damage. Cell Stress Chaperones (2014) 0.75
The role of C-reactive protein in innate and acquired inflammation: new perspectives. Inflamm Cell Signal (2016) 0.75
Regulation of Coronary Endothelial Function by Interactions between TNF-α, LOX-1 and Adiponectin in Apolipoprotein E Knockout Mice. J Vasc Res (2016) 0.75
Lectin-like oxidized low-density lipoprotein receptor-1 facilitates metastasis of gastric cancer through driving epithelial-mesenchymal transition and PI3K/Akt/GSK3β activation. Sci Rep (2017) 0.75
Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients. Sci Immunol (2016) 0.75
The effect of oxidized low-density lipoprotein combined with adriamycin on the proliferation of Eca-109 cell line. Lipids Health Dis (2011) 0.75
Signatures of reproductive events on blood counts and biomarkers of inflammation: Implications for chronic disease risk. PLoS One (2017) 0.75
LOX-1 and Its Splice Variants: A New Challenge for Atherosclerosis and Cancer-Targeted Therapies. Int J Mol Sci (2017) 0.75
Clinical association of baseline levels of conjugated dienes in low-density lipoprotein and nitric oxide with aggressive B-cell non-Hodgkin lymphoma and their relationship with immunoglobulins and Th1-to-Th2 ratio. J Blood Med (2016) 0.75
Prevalence of Takotsubo cardiomyopathy in the United States. Am Heart J (2012) 3.15
Emergence of a highly pathogenic porcine reproductive and respiratory syndrome virus in the Mid-Eastern region of China. Vet J (2007) 2.91
Role of caspases in Ox-LDL-induced apoptotic cascade in human coronary artery endothelial cells. Circ Res (2003) 2.08
Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation (2004) 2.07
The Effect of Metformin Use on Left Ventricular Ejection Fraction and Mortality Post-Myocardial Infarction. Cardiovasc Drugs Ther (2015) 2.00
Dietary recommendations in the prevention and treatment of coronary heart disease: do we have the ideal diet yet? Am J Cardiol (2004) 1.74
Modulation of angiotensin II-mediated hypertension and cardiac remodeling by lectin-like oxidized low-density lipoprotein receptor-1 deletion. Hypertension (2008) 1.58
Effect of Joint National Committee VII report on hospitalizations for hypertensive emergencies in the United States. Am J Cardiol (2011) 1.58
Relation of microalbuminuria and coronary artery disease in patients with and without diabetes mellitus. Am J Cardiol (2006) 1.56
Multislice computed tomography in an asymptomatic high-risk population. Am J Cardiol (2006) 1.54
Assessment of left ventricular function: comparison of cardiac multidetector-row computed tomography with two-dimension standard echocardiography for assessment of left ventricular function. Int J Cardiovasc Imaging (2007) 1.49
Glucagon-like peptide-1 receptor agonist liraglutide inhibits endothelin-1 in endothelial cell by repressing nuclear factor-kappa B activation. Cardiovasc Drugs Ther (2013) 1.48
Myocardial protection during off pump coronary artery bypass surgery: a comparison of inhalational anesthesia with sevoflurane or desflurane and total intravenous anesthesia. Ann Card Anaesth (2013) 1.43
Adherence junction proteins in angiogenesis: modulation by aspirin and salicylic acid. J Cardiovasc Med (Hagerstown) (2012) 1.42
Eicosapentanoic acid inhibits hypoxia-reoxygenation-induced injury by attenuating upregulation of MMP-1 in adult rat myocytes. Cardiovasc Res (2003) 1.41
LOX-1 mediates oxidized low-density lipoprotein-induced expression of matrix metalloproteinases in human coronary artery endothelial cells. Circulation (2003) 1.40
Angiotensin II regulation of collagen type I expression in cardiac fibroblasts: modulation by PPAR-gamma ligand pioglitazone. Hypertension (2004) 1.38
High-risk acute coronary syndrome patient and cardiac biomarkers in the emergency department: where do we stand? Eur Heart J (2007) 1.38
Using recombinant tissue plasminogen activator to treat acute ischemic stroke in China: analysis of the results from the Chinese National Stroke Registry (CNSR). Stroke (2011) 1.37
Transforming growth factor beta receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin II. Circ Res (2004) 1.35
Oxidized LDL, LOX-1 and atherosclerosis. Cardiovasc Drugs Ther (2011) 1.33
Oxidative stress in cardiovascular disease: molecular basis of its deleterious effects, its detection, and therapeutic considerations. Curr Opin Cardiol (2004) 1.28
Assessing the credibility of the "YouTube approach" to health information on acute myocardial infarction. Clin Cardiol (2012) 1.26
Small concentrations of oxLDL induce capillary tube formation from endothelial cells via LOX-1-dependent redox-sensitive pathway. Arterioscler Thromb Vasc Biol (2007) 1.24
Oxidized LDL, a critical factor in atherogenesis. Cardiovasc Res (2005) 1.22
Regulatory role of endothelium in the expression of genes affecting arterial calcification. Biochem Biophys Res Commun (2004) 1.20
In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarction. Circ Res (2005) 1.20
Oxidant stress in mitochondrial DNA damage, autophagy and inflammation in atherosclerosis. Sci Rep (2013) 1.17
Association of scavenger receptors in adipose tissue with insulin resistance in nondiabetic humans. Arterioscler Thromb Vasc Biol (2009) 1.17
Genetic analysis of porcine circovirus type 2 (PCV2) strains isolated between 2001 and 2009: genotype PCV2b predominate in postweaning multisystemic wasting syndrome occurrences in eastern China. Virus Genes (2009) 1.16
Current Concepts of the Role of Oxidized LDL Receptors in Atherosclerosis. Curr Atheroscler Rep (2012) 1.16
Regulation of autophagy and apoptosis in response to ox-LDL in vascular smooth muscle cells, and the modulatory effects of the microRNA hsa-let-7 g. Int J Cardiol (2013) 1.15
Molecular imaging of atherosclerotic plaques targeted to oxidized LDL receptor LOX-1 by SPECT/CT and magnetic resonance. Circ Cardiovasc Imaging (2010) 1.14
Cross-talk between dyslipidemia and renin-angiotensin system and the role of LOX-1 and MAPK in atherogenesis studies with the combined use of rosuvastatin and candesartan. Atherosclerosis (2005) 1.14
Loss of exercise-induced cardioprotection after cessation of exercise. J Appl Physiol (1985) (2003) 1.12
MicroRNA-29, a mysterious regulator in myocardial fibrosis and circulating miR-29a as a biomarker. J Am Coll Cardiol (2014) 1.12
Effect of statins on fasting plasma glucose in diabetic and nondiabetic patients. J Investig Med (2009) 1.12
Oxidized low-density lipoprotein and atherosclerosis implications in antioxidant therapy. Am J Med Sci (2011) 1.12
Common carotid artery wall thickness and external diameter as predictors of prevalent and incident cardiac events in a large population study. Cardiovasc Ultrasound (2007) 1.12
Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells: role of LOX-1. J Pharmacol Exp Ther (2002) 1.10
Inhibition of atherogenesis in LDLR knockout mice by systemic delivery of adeno-associated virus type 2-hIL-10. Atherosclerosis (2005) 1.10
LOX-1, an oxidized LDL endothelial receptor, induces CD40/CD40L signaling in human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol (2003) 1.08
Statins increase thrombomodulin expression and function in human endothelial cells by a nitric oxide-dependent mechanism and counteract tumor necrosis factor alpha-induced thrombomodulin downregulation. Blood Coagul Fibrinolysis (2003) 1.07
Exercise training provides cardioprotection against ischemia-reperfusion induced apoptosis in young and old animals. Exp Gerontol (2005) 1.06
Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome. Am J Cardiol (2007) 1.06
ALDH2 protects against stroke by clearing 4-HNE. Cell Res (2013) 1.05
Common carotid arterial interadventitial distance (diameter) as an indicator of the damaging effects of age and atherosclerosis, a cross-sectional study of the Atherosclerosis Risk in Community Cohort Limited Access Data (ARICLAD), 1987-89. Cardiovasc Ultrasound (2006) 1.05
TGF-beta 1 attenuates myocardial ischemia-reperfusion injury via inhibition of upregulation of MMP-1. Am J Physiol Heart Circ Physiol (2003) 1.05
Human cytomegalovirus inhibits Akt-mediated eNOS activation through upregulating PTEN (phosphatase and tensin homolog deleted on chromosome 10). Cardiovasc Res (2005) 1.04
Anoxia-reoxygenation stimulates collagen type-I and MMP-1 expression in cardiac fibroblasts: modulation by the PPAR-gamma ligand pioglitazone. J Cardiovasc Pharmacol (2004) 1.03
LOX-1 deletion decreases collagen accumulation in atherosclerotic plaque in low-density lipoprotein receptor knockout mice fed a high-cholesterol diet. Cardiovasc Res (2008) 1.00
Mitochondrial dysfunction in a neural cell model of spinal muscular atrophy. J Neurosci Res (2009) 0.99
Angiotensin II induces capillary formation from endothelial cells via the LOX-1 dependent redox-sensitive pathway. Hypertension (2007) 0.98
Cholesterol-induced membrane microvesicles as novel carriers of damage-associated molecular patterns: mechanisms of formation, action, and detoxification. Arterioscler Thromb Vasc Biol (2012) 0.98
LOX-1 inhibition in myocardial ischemia-reperfusion injury: modulation of MMP-1 and inflammation. Am J Physiol Heart Circ Physiol (2002) 0.97
Oxidized LDL receptor 1 (OLR1) as a possible link between obesity, dyslipidemia and cancer. PLoS One (2011) 0.97
GM-CSF fused with GP3 and GP5 of porcine reproductive and respiratory syndrome virus increased the immune responses and protective efficacy against virulent PRRSV challenge. Virus Res (2009) 0.97
Follow-up of Glycemic Control and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med (2015) 0.96
Interactions between the renin-angiotensin system and dyslipidemia: relevance in the therapy of hypertension and coronary heart disease. Arch Intern Med (2003) 0.96
Genetic variation analysis of porcine reproductive and respiratory syndrome virus isolated in China from 2002 to 2007 based on ORF5. Vet Microbiol (2009) 0.96
TGF-β1 induces senescence of bone marrow mesenchymal stem cells via increase of mitochondrial ROS production. BMC Dev Biol (2014) 0.96
Exercise and cardioprotection. Curr Opin Cardiol (2002) 0.95
Role of oxidative stress in coronary heart disease. Indian Heart J (2004) 0.95
Comparison of outcomes of weekend versus weekday admissions for atrial fibrillation. Am J Cardiol (2012) 0.95
LOX-1, oxidative stress and inflammation: a novel mechanism for diabetic cardiovascular complications. Cardiovasc Drugs Ther (2011) 0.95
Niemann-Pick disease resulting in spontaneous splenic rupture in an adult: report of a case. Surg Today (2008) 0.95
Determining the significance of side branch lesion during bifurcation stenting. Am J Cardiol (2011) 0.95
MnSOD antisense treatment and exercise-induced protection against arrhythmias. Free Radic Biol Med (2004) 0.94
Regulation of TGFbeta1-mediated collagen formation by LOX-1: studies based on forced overexpression of TGFbeta1 in wild-type and lox-1 knock-out mouse cardiac fibroblasts. J Biol Chem (2008) 0.93
LOX-1 abrogation reduces myocardial ischemia-reperfusion injury in mice. J Mol Cell Cardiol (2007) 0.93
LOX-1 deletion alters signals of myocardial remodeling immediately after ischemia-reperfusion. Cardiovasc Res (2007) 0.93
Triad of metabolic syndrome, chronic kidney disease, and coronary heart disease with a focus on microalbuminuria death by overeating. J Am Coll Cardiol (2011) 0.93
Angiotensin II-mediated oxidative stress and procollagen-1 expression in cardiac fibroblasts: blockade by pravastatin and pioglitazone. Am J Physiol Heart Circ Physiol (2006) 0.93
Expression of lectin-like oxidized low-density lipoprotein receptors during ischemia-reperfusion and its role in determination of apoptosis and left ventricular dysfunction. J Am Coll Cardiol (2003) 0.92
Cannabinoids and atherosclerotic coronary heart disease. Clin Cardiol (2012) 0.92
Intracellular signaling of LOX-1 in endothelial cell apoptosis. Circ Res (2009) 0.92
Enhanced immune responses of mice inoculated recombinant adenoviruses expressing GP5 by fusion with GP3 and/or GP4 of PRRS virus. Virus Res (2008) 0.92
Over-expression of angiotensin II type 2 receptor (agtr2) reduces atherogenesis and modulates LOX-1, endothelial nitric oxide synthase and heme-oxygenase-1 expression. Atherosclerosis (2007) 0.92
Generation of robust cytotoxic T lymphocytes against prostate specific antigen by transduction of dendritic cells using protein and recombinant adeno-associated virus. Cancer Immunol Immunother (2007) 0.92
Modulation of ADP-induced platelet activation by aspirin and pravastatin: role of lectin-like oxidized low-density lipoprotein receptor-1, nitric oxide, oxidative stress, and inside-out integrin signaling. J Pharmacol Exp Ther (2007) 0.92
Expression of EphA2 and E-cadherin in gastric cancer: correlated with tumor progression and lymphogenous metastasis. Pathol Oncol Res (2009) 0.92
Molecular dissection of angiotensin II-activated human LOX-1 promoter. Arterioscler Thromb Vasc Biol (2006) 0.91
Prevention of heart failure. Curr Opin Cardiol (2006) 0.91
DPP-4 inhibitors repress NLRP3 inflammasome and interleukin-1beta via GLP-1 receptor in macrophages through protein kinase C pathway. Cardiovasc Drugs Ther (2014) 0.90
LOX-1 and angiotensin receptors, and their interplay. Cardiovasc Drugs Ther (2011) 0.90
Aspirin inhibits oxidant stress, reduces age-associated functional declines, and extends lifespan of Caenorhabditis elegans. Antioxid Redox Signal (2012) 0.90
Prior exposure to oxidized low-density lipoprotein limits apoptosis in subsequent generations of endothelial cells by altering promoter methylation. Am J Physiol Heart Circ Physiol (2011) 0.90